Fenretinide Treatment Accelerates Atherosclerosis Development in apoE‐deficient Mice in Spite of Beneficial Metabolic Effects
British Journal of Pharmacology - United States
doi 10.1111/bph.14869
Full Text
Open PDFAbstract
Available in full text
Categories
Date
November 14, 2019
Authors
Publisher
Wiley